Try our Advanced Search for more refined results

USA v. Babich et al

  1. July 01, 2020

    Insys Execs Can't Dodge Prison During Appeal, Seek Delay

    The First Circuit said Wednesday that Insys Therapeutics Inc. founder John Kapoor and other former executives can't dodge prison while they appeal convictions on charges of scheming to bribe doctors to prescribe the company's fentanyl spray, but they're asking the trial court to put off their prison surrender date.

  2. April 27, 2020

    Insys Founder's Prison Report Date Pushed Back Amid Virus

    Insys Therapeutics Inc. founder John Kapoor will not have to report to prison until July 21, a judge ruled Monday after defense attorneys and prosecutors sparred over whether the onetime billionaire could attempt to flee during the pandemic.

  3. April 24, 2020

    Insys Prosecutors To Appeal Part Of Landmark Guilty Verdict

    Federal prosecutors on Thursday signaled their intent to appeal part of a landmark verdict that convicted five former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, paving the way for a First Circuit battle over the reach of the Controlled Substances Act.

  4. March 26, 2020

    Convicted Insys Exec Says Forfeiture Unfair In Bear Market

    An Insys Therapeutics Inc. executive convicted for his role in a scheme to bribe doctors to prescribe opioids is asking a Massachusetts federal judge to rethink an order forcing him to forfeit $3.4 million, saying that most of his assets are in the stock market and the court should either cancel the forfeiture or give the markets time to recover from the coronavirus pandemic.

  5. March 13, 2020

    Insys Execs Say Virus Could Further Delay Surrender Dates

    Insys Therapeutics Inc. founder John Kapoor and five other executives of the opioid company won a short postponement of their prison sentences Friday and said they might seek a further delay due to the coronavirus pandemic.

  6. March 05, 2020

    Insys Execs Can't Delay Prison In Opioid Kickback Case

    Insys Therapeutics Inc. founder John Kapoor and four underlings cannot delay serving their prison sentences while they appeal their convictions in a racketeering scheme to bribe doctors to prescribe opioids, a judge ruled Thursday, saying the defendants are unlikely to win on appeal.

  7. February 25, 2020

    Feds Say Insys' Kapoor Should Be On Hook For $60M Tab

    Federal prosecutors argued Tuesday that Insys Therapeutics Inc. founder John Kapoor should be responsible for the nearly $60 million due to insurers and victims of his company's scheme to bribe doctors to prescribe opioids, while his lawyers said in court Kapoor may "resist" paying if his liability isn't capped.

  8. February 24, 2020

    Insys Should Pay Half Of $57M Restitution, Founder Says

    Insys Therapeutics Inc. founder John Kapoor argued in a late Sunday filing that the now-bankrupt company should pay half of a $57 million restitution order over a scheme to bribe doctors to prescribe its opioids, while he and two former bigwigs should pay the lion's share of the remaining amount owed.

  9. February 14, 2020

    Insys Execs Owe $57M To Insurers And Victims, Judge Rules

    Seven former Insys Therapeutics Inc. executives convicted of bribing doctors to prescribe opioids were ordered by a federal judge Friday to pay nearly $57 million in restitution to insurance companies and individual victims impacted by the scheme, less than one-fifth of what prosecutors sought.

  10. February 04, 2020

    Insys Execs Say Assumptions Don't Equal $300M Restitution

    Lawyers for seven former Insys Therapeutics Inc. executives convicted of bribing doctors to prescribe opioids told a federal judge Tuesday that the government's $300 million-plus restitution claim is based on assumptions and should be much lower.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!